Aminolevulinic Acid
(ZLHFONARZHCSET-UHFFFAOYSA-N)
Structure
- SMILES
- NCC(=O)CCC(=O)O.Cl
- Molecular Formula:
- C5H10ClNO3
- Molecular Weight:
- 167.591
- Log P:
- 0.8813
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 3
- TPSA:
- 80.39
- CAS Number(s):
- 5451-09-2
Synonym(s)
1.
Aminolevulinic Acid
2.
5-Aminolaevulinate
3.
5-Aminolevulinate
4.
Aminolevulinic Acid Hydrochloride
5.
Delta-Aminolevulinic Acid
6.
Levulan
7.
5 Aminolaevulinate
8.
5 Aminolevulinate
9.
Acid Hydrochloride, Aminolevulinic
10.
Acid, Aminolevulinic
11.
Acid, Delta-Aminolevulinic
12.
Delta Aminolevulinic Acid
13.
Hydrochloride, Aminolevulinic Acid
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Wrong technique in product usage process | FAERS: 29 | US FAERS | |
| 2 | Drug ineffective | FAERS: 23 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 3 | Application site erythema | FAERS: 20 | US FAERS | |
| 4 | Application site pain | FAERS: 17 | US FAERS | |
| 5 | treatment failure | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Erythema | FAERS: 16 | US FAERS | |
| 7 | Laceration | FAERS: 13 | US FAERS | |
| 8 | Application site swelling | FAERS: 9 | US FAERS | |
| 9 | Eye pain | FAERS: 9 | US FAERS | |
| 10 | Photophobia | FAERS: 9 | US FAERS | |
| 11 | Pain | FAERS: 8 | US FAERS | |
| 12 | Accidental exposure to product | FAERS: 7 | US FAERS | |
| 13 | Application site vesicles | FAERS: 7 | US FAERS | |
| 14 | Application site burn | FAERS: 6 | US FAERS | |
| 15 | Eye irritation | FAERS: 6 | US FAERS | |
| 16 | Application site pustules | FAERS: 5 | US FAERS | |
| 17 | Burning sensation | FAERS: 5 | US FAERS | |
| 18 | Application site pruritus | FAERS: 4 | US FAERS | |
| 19 | Application site reaction | FAERS: 4 | US FAERS | |
| 20 | Blepharitis | FAERS: 4 | US FAERS | |
| 21 | Eye Burns | FAERS: 4 | US FAERS | |
| 22 | Nonspecific reaction | FAERS: 4 | US FAERS | |
| 23 | Application site exfoliation | FAERS: 3 | US FAERS | |
| 24 | Application site rash | FAERS: 3 | US FAERS | |
| 25 | Cerebrovascular accident | FAERS: 3 | US FAERS | |
| 26 | Dysgeusia | FAERS: 3 | US FAERS | |
| 27 | Hypotension | FAERS: 3 | US FAERS | |
| 28 | Malaise | FAERS: 3 | US FAERS | |
| 29 | Nausea | FAERS: 3 | US FAERS | |
| 30 | Post procedural complication | FAERS: 3 | US FAERS | |
| 31 | Product package associated injury | FAERS: 3 | US FAERS | |
| 32 | Product quality issue | FAERS: 3 | US FAERS | |
| 33 | Scab | FAERS: 3 | US FAERS | |
| 34 | Therapy non-responder | FAERS: 3 | US FAERS | |
| 35 | Chest Pain | FAERS: 2 | US FAERS | |
| 36 | Device Failure | FAERS: 2 | US FAERS | |
| 37 | Disorientation | FAERS: 2 | US FAERS | |
| 38 | Facial Pain | FAERS: 2 | US FAERS | |
| 39 | Pneumonia | FAERS: 2 | US FAERS | |
| 40 | Product administration error | FAERS: 2 | US FAERS | |
| 41 | Product complaint | FAERS: 2 | US FAERS | |
| 42 | Product use issue | FAERS: 2 | US FAERS | |
| 43 | Pruritus | FAERS: 2 | US FAERS | |
| 44 | Skin tightness | FAERS: 2 | US FAERS | |
| 45 | Temperature intolerance | FAERS: 2 | US FAERS | |
| 46 | Visual Impairment | FAERS: 2 | US FAERS | |
| 47 | Vomiting | FAERS: 2 | US FAERS | |
| 48 | Abasia | FAERS: 1 | US FAERS | |
| 49 | Administration site discomfort | FAERS: 1 | US FAERS | |
| 50 | Alopecia | FAERS: 1 | US FAERS | |
| 51 | Application site cellulitis | FAERS: 1 | US FAERS | |
| 52 | Application site infection | FAERS: 1 | US FAERS | |
| 53 | Application site inflammation | FAERS: 1 | US FAERS | |
| 54 | Application site irritation | FAERS: 1 | US FAERS | |
| 55 | Application site laceration | FAERS: 1 | US FAERS | |
| 56 | Application site papules | FAERS: 1 | US FAERS | |
| 57 | Application site scab | FAERS: 1 | US FAERS | |
| 58 | Application site scar | FAERS: 1 | US FAERS | |
| 59 | Application site streaking | FAERS: 1 | US FAERS | |
| 60 | Application site urticaria | FAERS: 1 | US FAERS | |
| 61 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 62 | Back Pain | FAERS: 1 | US FAERS | |
| 63 | Basal cell carcinoma | FAERS: 1 | US FAERS | |
| 64 | Blister rupture | FAERS: 1 | US FAERS | |
| 65 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 66 | Cataract | FAERS: 1 | US FAERS | |
| 67 | Chemical injury | FAERS: 1 | US FAERS | |
| 68 | Chills | FAERS: 1 | US FAERS | |
| 69 | Conjunctivitis | FAERS: 1 | US FAERS | |
| 70 | Delirium | FAERS: 1 | US FAERS | |
| 71 | Dermatitis acneiform | FAERS: 1 | US FAERS | |
| 72 | Diplopia | FAERS: 1 | US FAERS | |
| 73 | Drug administration error | FAERS: 1 | US FAERS | |
| 74 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 75 | Dyschromatopsia | FAERS: 1 | US FAERS | |
| 76 | Ecchymosis | FAERS: 1 | US FAERS | |
| 77 | Electrocardiogram ST segment abnormal | FAERS: 1 | US FAERS | |
| 78 | Electrolyte imbalance | FAERS: 1 | US FAERS | |
| 79 | Embolic stroke | FAERS: 1 | US FAERS | |
| 80 | Encephalomyelitis | FAERS: 1 | US FAERS | |
| 81 | Epistaxis | FAERS: 1 | US FAERS | |
| 82 | Eye Infection | FAERS: 1 | US FAERS | |
| 83 | Eye complication associated with device | FAERS: 1 | US FAERS | |
| 84 | Fatigue | FAERS: 1 | US FAERS | |
| 85 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 86 | Foreign body sensation in eyes | FAERS: 1 | US FAERS | |
| 87 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 88 | Headache | FAERS: 1 | US FAERS | |
| 89 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 90 | Hypoxia | FAERS: 1 | US FAERS | |
| 91 | Iatrogenic injury | FAERS: 1 | US FAERS | |
| 92 | Ileus | FAERS: 1 | US FAERS | |
| 93 | Impaired work ability | FAERS: 1 | US FAERS | |
| 94 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 95 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 96 | Infection | FAERS: 1 | US FAERS | |
| 97 | Inflammation | FAERS: 1 | US FAERS | |
| 98 | Injury associated with device | FAERS: 1 | US FAERS | |
| 99 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 100 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 101 | Medication Error | FAERS: 1 | US FAERS | |
| 102 | Memory impairment | FAERS: 1 | US FAERS | |
| 103 | Multiple Sclerosis | FAERS: 1 | US FAERS | |
| 104 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 105 | Overdose | FAERS: 1 | US FAERS | |
| 106 | Packaging design issue | FAERS: 1 | US FAERS | |
| 107 | Patient dissatisfaction with treatment | FAERS: 1 | US FAERS | |
| 108 | Periorbital disorder | FAERS: 1 | US FAERS | |
| 109 | Pneumothorax | FAERS: 1 | US FAERS | |
| 110 | Procedural complication | FAERS: 1 | US FAERS | |
| 111 | Procedural hypotension | FAERS: 1 | US FAERS | |
| 112 | Product appearance confusion | FAERS: 1 | US FAERS | |
| 113 | Product label issue | FAERS: 1 | US FAERS | |
| 114 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 115 | Product physical consistency issue | FAERS: 1 | US FAERS | |
| 116 | Product physical issue | FAERS: 1 | US FAERS | |
| 117 | Punctate keratitis | FAERS: 1 | US FAERS | |
| 118 | Radiation skin injury | FAERS: 1 | US FAERS | |
| 119 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 120 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 121 | Sepsis | FAERS: 1 | US FAERS | |
| 122 | Sinus pain | FAERS: 1 | US FAERS | |
| 123 | Skin lesion | FAERS: 1 | US FAERS | |
| 124 | Sudden Cardiac Death | FAERS: 1 | US FAERS | |
| 125 | Therapeutic product effect incomplete | FAERS: 1 | US FAERS | |
| 126 | Throat irritation | FAERS: 1 | US FAERS | |
| 127 | Transient aphasia | FAERS: 1 | US FAERS | |
| 128 | Trichorrhexis | FAERS: 1 | US FAERS | |
| 129 | Ulcer | FAERS: 1 | US FAERS | |
| 130 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 131 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 132 | Actinic keratosis | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.